Test Price
1,100 AED✅ Home Collection Available
BCR-ABL Quantitative MRD Monitor Test in UAE | 1100 AED | 2026 DHA Guidelines
تحليل BCR-ABL الكمي لمراقبة المرض المتبقي الأدنى (MRD Monitor) في الإمارات | 1100 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي | Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing with Real-Time Quantitative PCR (qPCR) & Whole Genome Sequencing (WGS).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection; VIP Mobile Phlebotomy service ensuring sample integrity (DO NOT FREEZE).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview | نظرة عامة
The BCR-ABL Quantitative MRD Monitor test uses ultra-sensitive molecular methods to measure minimal residual disease (MRD) in patients with Philadelphia chromosome-positive leukemias, guiding precision therapy and early relapse detection. تجمع هذه التقنية بين تفاعل البوليميراز المتسلسل الكمي (qPCR) وتسلسل الجينوم الكامل (WGS) لتقديم نتائج دقيقة وموثوقة.
| Feature | Our Test (Precision/Method/Speed) | Closest Alternative |
|---|---|---|
| Precision | Sensitivity down to MR4.5 (0.0032% IS) via qPCR validated by WGS | Standard RT-PCR, sensitivity often limited to MR3.0 |
| Method | Real-Time Quantitative PCR (qPCR) + Whole Genome Sequencing (WGS) | qPCR alone or digital PCR |
| Speed | Samples collected Mon/Wed/Fri by 9 AM; reports delivered Tue/Thu/Sat | Often 5–7 working days |
Physician Insight & Safety Protocol
“As a haematologist, I understand the anxiety behind MRD monitoring. This test provides a molecular compass for your treatment journey, but results must always be interpreted together with your full clinical picture. I emphasise that no single number defines your prognosis—we look at trends and response dynamics.” — Dr. Prabhakar Reddy, DHA License No. 61713011
Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Changing therapy based on test results without medical supervision can be life-threatening.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide a mandatory MRD Requisition Form (Form 22) with historical data; sample frozen instead of refrigerated; gross haemolysis.
- Emergency Red Flags: If you experience sudden fever, uncontrolled bleeding, severe bone pain, or neurological symptoms alongside new rising BCR-ABL levels, seek immediate emergency care.
- Pre-collection Note: Bone marrow specimens require an authorised clinician; whole blood must be collected in EDTA (Lavender Top) tube, refrigerated, DO NOT FREEZE.
Patient FAQ & Clinical Guidance
1. What is the purpose of BCR-ABL Quantitative MRD monitoring?
BCR-ABL quantitative MRD monitoring precisely measures residual leukemia cells to guide treatment decisions and detect early relapse. It quantifies the fusion transcript (bcr-abl) relative to a control gene, allowing oncologists to assess molecular remission depth (major molecular response, MR4.0, MR4.5). Regular monitoring is essential in chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL) to adjust tyrosine kinase inhibitor therapy or consider allogeneic transplant timing.
يقيس اختبار BCR-ABL الكمي لمراقبة المرض المتبقي الأدنى بدقة الخلايا السرطانية المتبقية لتوجيه قرارات العلاج وكشف الانتكاس المبكر. يتم تحديد مستويات الطفرات الجينية BCR-ABL1 لتقييم عمق الاستجابة الجزيئية، مما يساعد أطباء الأورام على ضبط العلاج بمثبطات التيروزين كيناز.
2. How should I prepare for this?
A mandatory MRD Requisition Form (Form 22) with historical data must be completed; avoid freezing the sample. No fasting is required. For home collection, our phlebotomist will bring ice packs for refrigerated transport. Ensure you mention all current medications, including any supplements or over-the-counter drugs, on the form. Bone marrow samples require a scheduled hospital procedure; our team coordinates the entire logistics.
يجب استكمال نموذج طلب مراقبة المرض المتبقي الأدنى (نموذج 22) مع البيانات التاريخية دون تجميد العينة. لا يشترط الصيام. بالنسبة للجمع المنزلي، سيحضر فني المختبر حاويات مبردة للحفاظ على العينة.
3. What do the results mean and what should I do next?
A reduction in BCR-ABL transcript levels indicates molecular response; a rise may signal resistance or disease progression. Results are reported on the International Scale (IS) as a percentage. A 3‑log reduction (MR3) or deeper suggests effective therapy. Always discuss your report with your haematologist; never self-interpret trends. Our telephonic clinical guidance service provides immediate, personalised context for your numbers, bridging the gap between lab data and clinical action.
انخفاض مستويات BCR-ABL يشير إلى استجابة جزيئية، بينما قد يدل الارتفاع على مقاومة أو تطور المرض. تُعرض النتائج وفق المقياس الدولي (IS) كنسبة مئوية. استشارة طبيب أمراض الدم ضرورية قبل اتخاذ أي خطوة علاجية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians